Background: Obesity is a chronic disease that impairs quality of life and leads to several
comorbidities. When conservative therapies fail, bariatric surgical options such as Roux-en …

The obesity epidemic in the USA and worldwide is well documented and continues to grow.
Endoscopic metabolic and bariatric therapies may offer a less invasive approach than …

BACKGROUND Endoscopic sleeve gastroplasty (ESG) is an effective therapy for class I-II
obesity, but there are knowledge gaps in the published literature about its implementation in …

Background For high-risk classified patients, patients with superobesity and in cases of
contraindication to abdominal surgery, traditional bariatric surgery might lead to potential …

Background and Aims OverStitch devices (OverStitch and OverStitch Sx; Apollo
Endosurgery, Inc, Austin, Tex, USA) are used for a wide range of applications. A European …

Introduction ESG is an effective treatment for classes I and II obesity. However, the benefit of
ESG in patients with morbid obesity (BMI≥ 40 kg/m 2) who decline surgery is not known …

Since its first description in 2013, robust evidence supporting the efficacy and safety of the
endoscopic sleeve gastroplasty (ESG) has been on the rise. A large case series and meta …

Background Laparoscopic gastrojejunostomies are time consuming and require a specific
training. Alternatively, sutureless anastomosis can be achieved using endoscopically …

Abstract Purpose of Review Obesity is increasing at an alarming rate and now poses a
global threat to humankind. In recent years, we have seen the emergence of medical …

Background Endoscopic sleeve gastroplasty (ESG) is a minimally invasive endoscopic
weight loss procedure used to treat obesity. The long-term goal of this project is to develop a …